has recently proven t o be extremely e f f i c acious i n inducing i r o n excretionwhenadministered as an I V o r SC infusion. To determineappropriate IVdrugdoses f o r thalassemic children o f d i f f e r e n t ages, we performed 17 dose-response studies on patients from 5 t o 26 years old. Each c h i l d received 4 one-week courses o f I V DF a t doses o f 20, 40, 60 and 80n]/kg. Three pst i e n t s received SC DF by portable infusion pump a t 20 nlg/kg over 8 hours f o r one week and 16 hours another week. A t 20 mg/kg, drug e f f i c i e n c y (urinary i r o n excretion/theoretical maxinum excretion) was 55% i n the youngest group but f e l l r a p i d l y as the dose was increased. I n contrast,drugefficiency was 86% i n patients over 11 years and dropped o f f slowly t o 62% a t 80 mg/kg. At the same dose, SC DF given over 8 hours was shown t o be almost as effect i v e as 16 hours SC and 24 hours I V OF, permitting over-night SC administration. Thus, drug dose and route o f administration should be adjusted according t o age and requirements. Medical Center. i l s~a r t~i l e n t o f Pediatrics. New York. Patients w i t h hbmozygous 0-thalassemia o f t e n havemoderate t o severe epistaxis and/or a petechial rash w i t h normal p l a t e l e t count. PT and PTT. For t h i s reason we have studied p l a t e l e t fuiction(l'1 F). Pre-transfusion evaluation included: Duke bleeding time (BT). PFs release (Stypven) , aggregation (epinephrine, ADP, collagen), PT.PTT and p l a t e l e t count. PI F was abnormal I n 13/30 patients (43%) studled: 10/13had recurrent epistaxis and/or petechial rashes.3had minimal symptoms; 13/13 had abnormal aggregation wi t h epinephrine. 10/13withADP, and 10/13 w i t h collage?; only 1 also had s l i g h t l y low PF,release; BT was abnormal i n 3/13. A t time o f study platel e t count was normal i n a1 1. PT and PTT i n most; none were receivi n g antl-aggregating drugs. Patients' p l a t e l e t s were isolated. washed by Ardl i e b u f f e r method, lysed and analyzed spectophotometr i c a l l y f o r iron. No i r o n deposition i n p l a t e l e t s was detected by t h i s method. I n other experiments, donor p l a t e l e t s were washed o r g e l -f i l tered t o render them f r e e o f donor plasma; t e s t plasma was then added t o p l a t e l e t s and p l a t e l e t aggregation assays were perfomed. Normal donor p l a t e l e t s were abnormal when tested i n plasma from patients w i t h abnormal PI F; p l a t e l e t s from 3 patients w i !ti ab:co~n~al PI F functioned normally i n r~ormal plasma but abnormally i n "abnormal" plasma. Abnormalities o f p l a t e l e t aggregation are detectable i n 1/2 symptomatic patients. Our data suggest that the P1 F abnormalities detected i n 8-thalassemia may be due t o a plasma i n h i b i t o r , rather than an i n t r i n s i c p l a t e l e t defect. As the hct rises above 60% in CCHD, there is an increased threat of thrombotic and hemorrhagic complications due to blood hyperviscosi ty . Hyperviscosi ty has been attributed to increased RBC mass. Since RBC deformability is a determinant of viscosity and flow at high hcts, we studied RBC deformability in 22 children with polycythemic CCHD and in 10 controls, using a filtration system. Filterability is a function of cell deformability. Washed RBC's resuspended in Ringer's lactate-albumin solution were passed through a 3u polycarbonate filter using hydrostatic pressure (at 25*~), and flow velocity was calculated (ul/sec).
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STIFFENED ERYTHROCYTES IN POLYCYTHEMIA OF CYANOTIC

CONGENITAL HEART DISEASE (CCHD)
Controls had a mean hct of 413t 2, mean MCV of 87fl+ 2, and mean RBC flow velocity of 5.0 ul/sec+.7. Children with CCHD were divided into 2 groups: 10 patients with hcts between 50-60: (mean 5:3+1), and 12 patients with hcts )60% (range 63-743. mean 67%+l). MGan flow velocity (3.4ul/sec+.Z) in the group with hcts )60% was significant1 y (p=.05) reduced as compared to controls and the<60% hct group. The latter had a mean flow velocity of 4.8ul/sec+.7, which was comparable to controls. All groups were similar in age (mean 9.5 yrs), sex ratio and MCV.
We conclude that RBC's become stiffened when the hct exceeds 60% in CCHD. Stiffened RBC's may contribute to the thrombotic complications observed in these patients. There was no relationship between initial platelet count, age and time to response. Of the 24 patients evaluable for long tern outcane 5/11 (45.4%) of controls failed to achieve a normal platelet count and required treatment, including splenectomy in 1. In the treated group 2/13 (15.4%) relapsed and 1 required splenectomy.
INTRACRANIAL CALCIFICATIONS
We conclude that early steroid treatment in acute I T.P in children restores normal platelet counts significantly sooner than in those not treated and should be instituted at the time of diagnosis to prevent early complications. 
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